Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Operations

v3.21.1
Condensed Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue    
Product revenue, net $ 44,531,000 $ 34,921,000
Revenue - related party 1,068,000 1,708,000
Net revenue 45,599,000 36,629,000
Operating expenses    
Cost of goods sold - product revenue 14,594,000 10,532,000
Research and development 61,275,000 75,236,000
Research and development - licenses acquired 2,834,000 6,090,000
Selling, general and administrative 61,166,000 55,590,000
Total operating expenses 139,869,000 147,448,000
Income (loss) from operations (94,270,000) (110,819,000)
Other income (expense)    
Interest income 1,518,000 2,559,000
Interest expense and financing fee (15,326,000) (11,849,000)
Change in fair value of derivative liability (1,189,000) (27,000)
Change in fair value of investments 6,418,000 0
Gain on deconsolidation of Caelum 0 18,476,000
Total other income (expense) (8,579,000) 9,159,000
Loss before income tax expense (102,849,000) (101,660,000)
Income tax expense 136,000 0
Net loss (102,985,000) (101,660,000)
Less: net loss attributable to non-controlling interests 56,459,000 61,700,000
Net loss attributable to common stockholders $ (46,526,000) $ (39,960,000)
Net loss per common share - basic and diluted $ (1.43) $ (1.86)
Net loss per common share attributable to non - controlling interests - basic and diluted (0.78) (1.13)
Net loss per common share attributable to common stockholders - basic and diluted $ (0.65) $ (0.73)
Weighted average common shares outstanding - basic and diluted 72,005,181 54,711,838